Paratek Pharmaceuticals, Inc. (PRTK): Price and Financial Metrics
Paratek Pharmaceuticals, Inc. (PRTK)
Today's Latest Price: $5.15 USD
0.04 (0.78%)
Updated Jul 2 4:00pm
Add PRTK to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
PRTK Stock Summary
- Paratek Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 7.09% of US listed stocks.
- With a price/sales ratio of 9.85, Paratek Pharmaceuticals Inc has a higher such ratio than 87.4% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -6.8 for Paratek Pharmaceuticals Inc; that's greater than it is for merely 2.53% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Paratek Pharmaceuticals Inc are GEVO, AQST, KALA, JAGX, and AVGR.
- PRTK's SEC filings can be seen here. And to visit Paratek Pharmaceuticals Inc's official web site, go to paratekpharma.com.
PRTK Daily Price Range
PRTK 52-Week Price Range
PRTK Stock Price Chart Technical Analysis Charts
PRTK Price/Volume Stats
| Current price | $5.15 | 52-week high | $5.89 |
| Prev. close | $5.11 | 52-week low | $2.50 |
| Day low | $5.01 | Volume | 483,749 |
| Day high | $5.35 | Avg. volume | 758,055 |
| 50-day MA | $4.57 | Dividend yield | N/A |
| 200-day MA | $3.91 | Market Cap | 222.13M |
Paratek Pharmaceuticals, Inc. (PRTK) Company Bio
Paratek Pharmaceuticals focuses on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry in the United States. The company was founded in 1996 and is based in in Boston, Massachusetts.
Loading social stream, please wait...